Ozempic and Trulicity: Top Medicare Drug Spending Revealed in AARP Report

Economy

1 year ago

News sources:

Credited from: USATODAY

Ozempic and Trulicity are listed as two of the priciest drugs under Medicare, according to a report from the AARP Public Policy Institute.
These drugs have contributed nearly $50 billion in costs to Medicare in 2022, with average list prices having nearly doubled since their market introduction.
Of the 53 million Americans enrolled in Medicare, many struggle to afford their medications, leading to skipped doses or unfilled prescriptions.
The Inflation Reduction Act allows Medicare to negotiate drug prices, with expected discounts ranging from 38% to 79% starting in 2026.
AARP highlights the ongoing problem of price hikes and calls for enhanced negotiation powers for Medicare to better protect consumers.

For the full article, visit USA Today.